Xie Y - Search Results

1

Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling.

Wanjala J, Taylor BS, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Nanjangud GJ, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL, Carver BS. Wanjala J, et al. Among authors: xie y. Mol Cancer Ther. 2015 Jan;14(1):278-88. doi: 10.1158/1535-7163.MCT-14-0542-T. Epub 2014 Nov 7. Mol Cancer Ther. 2015. PMID: 25381262 Free PMC article.

2

Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.

Xie Y, Lu W, Liu S, Yang Q, Carver BS, Li E, Wang Y, Fazli L, Gleave M, Chen Z. Xie Y, et al. Mol Endocrinol. 2014 Oct;28(10):1629-39. doi: 10.1210/me.2014-1078. Epub 2014 Aug 6. Mol Endocrinol. 2014. PMID: 25099011 Free PMC article.

3

Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.

Xie Y, Liu S, Lu W, Yang Q, Williams KD, Binhazim AA, Carver BS, Matusik RJ, Chen Z. Xie Y, et al. Mol Oncol. 2014 Oct;8(7):1355-64. doi: 10.1016/j.molonc.2014.05.006. Epub 2014 May 21. Mol Oncol. 2014. PMID: 24910389 Free PMC article.

4

SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.

Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z. Lu W, et al. Among authors: xie y. Oncotarget. 2015 Jan 20;6(2):771-88. doi: 10.18632/oncotarget.2718. Oncotarget. 2015. PMID: 25596733 Free PMC article.

5

MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.

Xie Y, Lu W, Liu S, Yang Q, Goodwin JS, Sathyanarayana SA, Pratap S, Chen Z. Xie Y, et al. Oncotarget. 2016 Jul 26;7(30):47609-47619. doi: 10.18632/oncotarget.10251. Oncotarget. 2016. PMID: 27356744 Free PMC article.

6

Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer.

Xie Y, Fan H, Lu W, Yang Q, Nurkesh A, Yeleussizov T, Maipas A, Lu J, Manarbek L, Chen Z, Benassi E. Xie Y, et al. Oncogene. 2019 Apr;38(16):2967-2983. doi: 10.1038/s41388-018-0608-2. Epub 2018 Dec 19. Oncogene. 2019. PMID: 30568225 Free PMC article.

7

ARF represses androgen receptor transactivation in prostate cancer.

Lu W, Xie Y, Ma Y, Matusik RJ, Chen Z. Lu W, et al. Among authors: xie y. Mol Endocrinol. 2013 Apr;27(4):635-48. doi: 10.1210/me.2012-1294. Epub 2013 Feb 28. Mol Endocrinol. 2013. PMID: 23449888 Free PMC article.

8

Tumor Promoting Aspects of Senescence in Cancer Progression.

Yang Q, Xie Y, Miao L. Yang Q, et al. Among authors: xie y. Cancer Invest. 2016;34(9):452-458. doi: 10.1080/07357907.2016.1227443. Epub 2016 Oct 18. Cancer Invest. 2016. PMID: 27753505

9

MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.

Kanagasabai T, Li G, Shen TH, Gladoun N, Castillo-Martin M, Celada SI, Xie Y, Brown LK, Mark ZA, Ochieng J, Ballard BR, Cordon-Cardo C, Adunyah SE, Jin R, Matusik RJ, Chen Z. Kanagasabai T, et al. Among authors: xie y. Cancer Lett. 2022 Jan 28;525:46-54. doi: 10.1016/j.canlet.2021.09.041. Epub 2021 Oct 2. Cancer Lett. 2022. PMID: 34610416

10

Analysis of origin and protein-protein interaction maps suggests distinct oncogenic role of nuclear EGFR during cancer evolution.

Sharip A, Abdukhakimova D, Wang X, Kim A, Kim Y, Sharip A, Orakov A, Miao L, Sun Q, Chen Y, Chen Z, Xie Y. Sharip A, et al. Among authors: xie y. J Cancer. 2017 Mar 12;8(5):903-912. doi: 10.7150/jca.17961. eCollection 2017. J Cancer. 2017. PMID: 28382154 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,183 results

Search Page

Filters